Your posts are well thought out for the most part. But Nader and the team are very well aware of the potential applications. They may not have fully vetted them all, but they are well aware of all of the CCR5 associations in cancer.

Im looking forward to being cash rush, so they can continue to bring on elite talent to fully develop all of these indications. At that point we won't care how much NP knows about any particular Indication.